Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.

ABSTRACT:

SUBMITTER: Cook DP 

PROVIDER: S-EPMC11657065 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature